Glucocorticoid-induced osteoporosis, the leading cause of secondary osteoporosis, is characterized by diminished bone density and compromised osteoblast function. As current treatment options often ...
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
A small study published in 2021 on mice showed that the amino acids in bone broth may help protect against intestinal damage from ulcerative colitis, but this effect has not been observed in humans.
Mass Effect 5 is officially in the works from BioWare. First revealed back in 2020 with a brief teaser that sparked excitement among fans of the beloved sci-fi RPG, it's been some time since we've ...
The phenotypic diversity, differences in underlying pathogenesis and the secondary effects of medications administerd to ameliorate symptoms, such as those of hyperandrogenism, and outcomes ...
Tariffs often result in unwanted side effects, such as higher consumer prices. Tariffs have a long and contentious history, and the debate over whether they represent good or bad policy rages on t ...
She expressed, "I'm kind of in shock right now because I wasn't expecting this. Ozempic can cause bone density loss, and I didn't think that would happen to me since I was only on it for a year.
Glucocorticoids have a dose-dependent effect on serious infection risk—at higher doses risk of infection with glucocorticoids is substantially greater than with other immunomodulatory therapies, and ...
Despite its extensive use and popularity, aspartame has become a source of controversy in recent years, with some research suggesting the sweetener has adverse health effects. It is not clear if ...